# Enhancement of Corticosteroid Efficacy in COPD

> **NCT02340520** · PHASE3 · COMPLETED · sponsor: **UConn Health** · enrollment: 13 (actual)

## Conditions studied

- COPD

## Interventions

- **DRUG:** Theophylline
- **DRUG:** Roflumilast

## Key facts

- **NCT ID:** NCT02340520
- **Lead sponsor:** UConn Health
- **Sponsor class:** OTHER
- **Phase:** PHASE3
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2014-12
- **Primary completion:** 2016-08
- **Final completion:** 2016-08
- **Target enrollment:** 13 (ACTUAL)
- **Last updated:** 2018-06-19


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT02340520

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT02340520, "Enhancement of Corticosteroid Efficacy in COPD". Retrieved via AI Analytics 2026-07-12 from https://api.ai-analytics.org/clinical/NCT02340520. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*